Neurocrine Biosciences shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurocrine Biosciences by Assenagon Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $3.4M | 30k | 115.22 |
2024-06-30 | $34M | 249k | 137.67 |
2024-03-31 | $47M | 338k | 137.92 |
2023-12-31 | $42M | 316k | 131.76 |
2023-09-30 | $66M | 585k | 112.50 |
2023-06-30 | $25M | 265k | 94.30 |
2023-03-31 | $9.2M | 91k | 101.22 |
2022-12-31 | $25M | 208k | 119.44 |
2022-09-30 | $9.0M | 85k | 106.22 |
2022-06-30 | $14M | 140k | 97.48 |
2022-03-31 | $1.3M | 14k | 93.72 |
2021-12-31 | $7.3M | 86k | 85.17 |
2021-09-30 | $1.1M | 11k | 95.88 |
2021-06-30 | $4.8M | 49k | 97.31 |
2021-03-31 | $314k | 3.2k | 97.12 |
2020-06-30 | $2.8M | 23k | 122.00 |
2019-09-30 | $2.2M | 25k | 90.09 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management